HOME          ABOUT US          INVESTORS          INVENTORS          PORTFOLIO          CONTACT US


Home Page

About Us

Investors

Inventors

Portfolio

Contact Us

Privacy Policy

Portfolio - PGxl Laboratories, LLC

Incorporated:    February 2004
Contacts:    Roland Valdes, Jr., Ph.D., Founder and President
Description:    PGxl Laboratories, the first CLIA-certified lab of its kind, provides DNA testing for patient sensitivity to a broad range of common drugs, thereby reducing risky and costly adverse drug reactions (ADRs).

Because it is DNA-based, each PGxl test provides information that is applicable throughout a patient's life. PGX testing is already being recommended by the FDA before the prescription of certain drugs.

PGxl has an operating lab in MedCenter 3 and is generating revenue. The company is exploring additional funding sources to expand operations and marketing efforts.
Web Site:    http://www.pgxlab.com/
Other Resources:    See coverage of Dr. Valdes' research at the University of Louisville at:

  • UofL Medicine Magazine: University of Louisville laboratory uses new science to improve drug dosing (External Link)

  • UofL Medicine Magazine: UofL startup PGXL Laboratories acquires significant funding (External Link)







    • July 16, 2010
    Intrepid Bioinformatics Receives Investment, Meets Milestones

    May 6, 2010
    MetaCyte Business Lab Receives Mention in Nature (PDF)

    March 31, 2010
    MetaCyte Recognized for Innovation

    March 15, 2010
    Teresa Leezer Honored a Second Time for Excellence in Business Management

    February 23, 2010
    Gailar Addresses Leaders as Part of Innovation Panel

    January 2010
    Triathlon Medical Ventures and the Kentucky Seed Capital Fund Lead Investment in Louisville Start-Up

    November 2009
    MetaCyte Advisor Bill Strench Featured in Business First (External Link)

    November 2009
    EndoProtech Awarded $270,000 from Kentucky Cabinet for Economic Development

    		 August 25, 2009
    Pierce Named Interim Head of UofL Research (External Link)

    July 1, 2009
    AllTranz Named Top Innovator by National Venture Group

    May 8, 2009
    ApoImmune Finalist for "Best Early-Stage Vaccine Biotech" at World Vaccine Congress ViE Awards

    September 12, 2008
    MetaCyte Team Shows Off New Offices

    June 18, 2008
    Teresa Leezer Honored by Cambridge Who's Who for Excellence in Business Management

    Summer 2006
    A UofL research team led by Fred Roisen, Ph.D., has developed a breakthrough adult stem-cell therapy that repairs spinal-cord damage in paralyzed rats (External Link)



    Copyright © 2010 MetaCyte Business Lab LLC. All rights reserved. | Privacy Policy | Contact Us